Delek US price target raised to $39 from $36 at Piper Sandler
Piper Sandler raised the firm’s price target on Delek US (DK) to $39 from $36 and keeps an Overweight rating on the shares. The firm notes the company has a history of complicated quarterly results, and Q3 was no exception. While the headline result felt more like an exercise in non-recurring assumptions, even by Delek’s standards, the underlying Q3 result was solid, Piper argues.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.